Search

Search Results
Results 83231 - 83240 of 85911 for ADD
  • Zempreon CFC-Free Inhaler
    Drug - 29 May 2026
    Consumer Medicine Information (CMI) about Zempreon CFC-Free Inhaler intended for persons living in Australia.
  • Asmol CFC-Free Inhaler (with counter)
    Drug - 29 May 2026
    Consumer Medicine Information (CMI) about Asmol CFC-Free Inhaler (with counter) intended for persons living in Australia.
  • Enidin
    Drug - 29 May 2026
    Consumer Medicine Information (CMI) about Enidin intended for persons living in Australia.
  • Alphagan
    Drug - 29 May 2026
    Consumer Medicine Information (CMI) about Alphagan intended for persons living in Australia.
  • Neoral
    Drug - 7 May 2026
    Consumer Medicine Information (CMI) about Neoral intended for persons living in Australia.
  • Validation and qualification in the 2022 EU GMP Annex 1 revision
    White Paper - 4 May 2026
    An overview of the validation and qualification requirements introduced in the 2022 EU GMP Annex 1 revision, with a focus on sterile manufacturing and contamination control.
  • Lipid nanoparticles in drug delivery
    White Paper - 30 Apr 2026
    Lipid nanoparticles address key drug delivery challenges, including immune evasion, toxicity, and regulatory approval.
  • Levetiracetam Viatris
    Drug - 24 Apr 2026
    Consumer Medicine Information (CMI) about Levetiracetam Viatris intended for persons living in Australia.
  • How arboviruse E Dimer vaccines improve safety by reducing antibody dependent enhancement
    White Paper - 23 Apr 2026
    Discover how arbovirus E Dimer vaccines are engineered to improve safety by minimizing antibody dependent enhancement.
  • Tepmetko
    Drug - 14 Apr 2026
    Consumer Medicine Information (CMI) about Tepmetko intended for persons living in Australia.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback